Prostate-specific membrane antigen (PSMA) expression in patients with metastatic triple negative breast cancer: Initial results of the PRISMA study

• Published in: Journal of clinical oncology Vol. 41; no. 16_suppl; p. 1025
• Main Authors: Nader Marta, Guilherme, Wimana, Zena, Taraji, Loubna, Critchi, Gabriela, Aftimos, Philippe Georges, Piccart-Gebhart, Martine J., Flamen, Patrick, Gebhart, Geraldine
• Format: Journal Article
• Language: English
• Published: 01.06.2023

1025 Background: Radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) prolongs survival of patients (pts) with prostate cancer. Preliminary immunohistochemistry (IHC)-based studies suggest that PSMA is highly expressed in triple negative breast cancer (TNBC). The PRISMA stud...